14 July 2014 by Marlene Rabinovitch
Harnessing Pathology of Pulmonary Hypertension to Therapeutic Advantage
Presented at the 1st Annual Drug Discovery and Development Symposium, July 14-15th 2014, Bethesda, USA
Additional key-words: endothelin receptor antagonists,BMPR2,PPARgamma,p53